The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carfilzomib-associated cardiovascular adverse events: A systematic review and meta-analysis.
 
Adam Justin Waxman
No Relationships to Disclose
 
Suparna Chandra Clasen
No Relationships to Disclose
 
Alfred L. Garfall
No Relationships to Disclose
 
Joseph R. Carver
Consulting or Advisory Role - Onyx
 
Dan T. Vogl
Consulting or Advisory Role - Amgen; Celgene; Karyopharm Therapeutics
Research Funding - Acetylon Pharmaceuticals (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Millennium (Inst)
 
Rupal O'Quinn
No Relationships to Disclose
 
Adam D. Cohen
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Janssen
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen
 
Edward Allen Stadtmauer
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda; Teva
 
Bonnie Ky
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Mateon Therapeutics; Roche; Roche
Research Funding - Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure
 
Brendan M. Weiss
No Relationships to Disclose